Norwalk Leslie V

Director · NBIX, ARVN, CVS, GMED

As of 2026-09-16, Norwalk Leslie V has 30 Form 4 transactions on record across 4 companies — 22 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $2.3MIndirect: $0$2.3Mas of 2026-09-16
  • Direct $2.3M
  • Indirect $0
GMEDdirect15,000 sh$1.1M
CVSdirect7,376 sh$677K
NBIXdirect2,140 sh$320K
ARVNdirect22,714 sh$185K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

NBIX · 19 trades
2026-07-29: Option exercise, 842 sh ($117K)2026-07-29: Option exercise, 842 sh ($0)2026-07-28: Sale, 1,250 sh ($228K)2026-06-04: Sale, 1,250 sh ($210K)2026-05-27: Award / grant, 2,624 sh ($0)2026-05-27: Award / grant, 1,284 sh ($0)2026-05-21: Option exercise, 1,659 sh ($0)2026-05-21: Option exercise, 1,659 sh ($0)2026-05-12: Sale, 3,810 sh ($591K)2025-12-16: Sale, 1,190 sh ($185K)2025-12-15: Option exercise, 8,276 sh ($764K)2025-12-15: Sale, 5,000 sh ($761K)2025-12-15: Option exercise, 1,724 sh ($146K)2025-12-15: Option exercise, 8,276 sh ($0)2025-12-15: Option exercise, 1,724 sh ($0)2025-05-22: Option exercise, 1,435 sh ($0)2025-05-22: Option exercise, 1,435 sh ($0)2025-05-21: Award / grant, 3,305 sh ($0)2025-05-21: Award / grant, 1,659 sh ($0)
ARVN · 4 trades
2026-06-24: Award / grant, 22,714 sh ($0)2026-06-24: Award / grant, 15,527 sh ($0)2025-06-25: Award / grant, 23,105 sh ($0)2025-06-25: Award / grant, 16,025 sh ($0)
GMED · 4 trades
2026-01-21: Award / grant, 15,000 sh ($0)2026-01-08: Sale, 2,000 sh ($202K)2025-12-12: Sale, 4,000 sh ($355K)2025-01-23: Award / grant, 15,000 sh ($0)
CVS · 3 trades
2026-05-14: Award / grant, 1,447 sh ($141K)2025-11-20: Award / grant, 1,652 sh ($126K)2025-05-15: Award / grant, 2,077 sh ($126K)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-07-28NBIXSale1,250 @ $182.01$228K−44.0% of holding1,588Form 4
2026-06-04NBIXSale1,250 @ $168.06$210K−30.6% of holding2,838Form 4
2026-05-12NBIXSale3,810 @ $155.01$591K−61.1% of holding2,429Form 4
2026-01-08GMEDSale2,000 @ $101.10$202K−16.1% of holding10,419Form 4
2025-12-16NBIXSale1,190 @ $155.09$185K−16.0% of holding6,239Form 4
2025-12-15NBIXSale5,000 @ $152.23$761K−40.2% of holding7,429Form 4
2025-12-12GMEDSale4,000 @ $88.85$355K−24.4% of holding12,419Form 4
23 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-07-29NBIXOption exercise8422,430Form 4
2026-07-29NBIXOption exercise8422,140Form 4
2026-06-24ARVNAward / grant22,71422,714Form 4
2026-06-24ARVNAward / grant15,52741,572Form 4
2026-05-27NBIXAward / grant2,6242,624Form 4
2026-05-27NBIXAward / grant1,2841,284Form 4
2026-05-21NBIXOption exercise1,6590Form 4
2026-05-21NBIXOption exercise1,6594,088Form 4
2026-05-14CVSAward / grant1,4477,376Form 4
2026-01-21GMEDAward / grant15,00015,000Form 4
2025-12-15NBIXOption exercise8,27610,705Form 4
2025-12-15NBIXOption exercise1,72412,429Form 4
2025-12-15NBIXOption exercise8,276557Form 4
2025-12-15NBIXOption exercise1,7240Form 4
2025-11-20CVSAward / grant1,6525,929Form 4
2025-06-25ARVNAward / grant23,10523,105Form 4
2025-06-25ARVNAward / grant16,02526,045Form 4
2025-05-22NBIXOption exercise1,4350Form 4
2025-05-22NBIXOption exercise1,4352,429Form 4
2025-05-21NBIXAward / grant3,3053,305Form 4
2025-05-21NBIXAward / grant1,6591,659Form 4
2025-05-15CVSAward / grant2,0774,277Form 4
2025-01-23GMEDAward / grant15,00015,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.